Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FloraPlus
- Development stage
- Unknown
- Lead developer
- GyneBio Pharma
- Modality
- Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Hydrogel Systems → Drug Delivery Systems, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Vaginal
01
Overview
FloraPlus is a gynecological therapy developed and marketed by GyneBio Pharma, primarily indicated for the treatment and prevention of vaginal flora imbalances, including bacterial vaginosis and vaginal candidiasis (yeast infections). It functions as a prebiotic treatment designed to restore the natural microbial ecosystem of the vagina. The formulation typically contains prebiotics that selectively stimulate the growth of beneficial *Lactobacillus* species, which are essential for maintaining an acidic vaginal pH and inhibiting the overgrowth of pathogenic microorganisms. Additionally, it may incorporate bio-active polysaccharide complexes (such as the 2QR-complex) that prevent the adhesion of harmful bacteria to the vaginal mucosa. FloraPlus is often classified as a medical device or a specialized pharmaceutical product intended to provide relief from symptoms like discharge, odor, and itchiness while promoting long-term vaginal health without the use of traditional antibiotics.
- Brand names
- FloraPlus
- Other names
- Multi-Gyn FloraPlus
Beyond the preview
Go deeper on FloraPlus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FloraPlus.